nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.00843	0.095	CrCbGaD
Cyamemazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.00542	0.061	CrCbGaD
Cyamemazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.00529	0.0596	CrCbGaD
Cyamemazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.00507	0.0572	CrCbGaD
Cyamemazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.00434	0.0489	CrCbGaD
Cyamemazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.00433	0.0488	CrCbGaD
Cyamemazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.00388	0.0437	CrCbGaD
Cyamemazine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.00379	0.0427	CrCbGaD
Cyamemazine—Promazine—ADRA1D—polycystic ovary syndrome	0.00376	0.0424	CrCbGaD
Cyamemazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.0037	0.0417	CrCbGaD
Cyamemazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.00365	0.0411	CrCbGaD
Cyamemazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.00356	0.0401	CrCbGaD
Cyamemazine—Imipramine—ADRA1D—polycystic ovary syndrome	0.00329	0.0371	CrCbGaD
Cyamemazine—Promazine—ADRA1B—polycystic ovary syndrome	0.00321	0.0361	CrCbGaD
Cyamemazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.00291	0.0328	CrCbGaD
Cyamemazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.00282	0.0318	CrCbGaD
Cyamemazine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00281	0.0316	CrCbGaD
Cyamemazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.00261	0.0294	CrCbGaD
Cyamemazine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.00255	0.0287	CrCbGaD
Cyamemazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.00249	0.0281	CrCbGaD
Cyamemazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.00246	0.0277	CrCbGaD
Cyamemazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.00242	0.0273	CrCbGaD
Cyamemazine—Promazine—ADRA1A—polycystic ovary syndrome	0.00216	0.0243	CrCbGaD
Cyamemazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.0019	0.0214	CrCbGaD
Cyamemazine—Imipramine—ADRA1A—polycystic ovary syndrome	0.00189	0.0213	CrCbGaD
Cyamemazine—HTR2C—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00101	0.00111	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00101	0.0011	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000995	0.00109	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000977	0.00107	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000976	0.00107	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00097	0.00106	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000968	0.00106	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000958	0.00105	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000952	0.00104	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00095	0.00104	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00093	0.00102	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000924	0.00101	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000898	0.000985	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000895	0.000983	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NPB—polycystic ovary syndrome	0.000893	0.00098	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000887	0.000974	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000885	0.000971	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000883	0.000969	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000881	0.000967	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00088	0.000966	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000871	0.000956	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000867	0.000952	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000865	0.000949	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000865	0.000949	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000856	0.000939	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000845	0.000927	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000829	0.00091	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000813	0.000892	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000808	0.000886	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000808	0.000886	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000803	0.000882	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000802	0.00088	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000793	0.000871	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000793	0.00087	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000791	0.000868	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000787	0.000864	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000785	0.000862	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000777	0.000853	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NPB—polycystic ovary syndrome	0.000776	0.000851	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000768	0.000843	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000763	0.000838	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000761	0.000836	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000754	0.000828	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000753	0.000826	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000752	0.000825	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000751	0.000824	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000745	0.000818	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000745	0.000818	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000743	0.000815	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000737	0.000809	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000733	0.000805	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000729	0.000801	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00072	0.00079	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00072	0.00079	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000718	0.000788	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000707	0.000776	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000706	0.000775	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000701	0.00077	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000701	0.00077	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000698	0.000766	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000697	0.000765	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000693	0.000761	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000689	0.000756	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000689	0.000756	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000687	0.000754	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000685	0.000752	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000682	0.000748	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000677	0.000743	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000676	0.000742	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000674	0.00074	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00067	0.000735	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000668	0.000733	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000658	0.000723	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000656	0.00072	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000654	0.000717	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000647	0.00071	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000647	0.00071	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000642	0.000704	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000642	0.000704	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000635	0.000697	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000635	0.000697	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000624	0.000684	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000612	0.000672	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000609	0.000668	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000605	0.000664	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000599	0.000657	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000598	0.000656	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000594	0.000652	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000588	0.000645	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000584	0.000641	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000577	0.000633	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000572	0.000627	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000561	0.000616	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000557	0.000611	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000547	0.0006	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000546	0.000599	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000534	0.000586	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00053	0.000582	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00052	0.000571	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000513	0.000563	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000511	0.00056	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000507	0.000557	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000499	0.000548	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000498	0.000547	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FST—polycystic ovary syndrome	0.000486	0.000534	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000483	0.000531	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00048	0.000527	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LHB—polycystic ovary syndrome	0.000475	0.000521	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000474	0.00052	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000465	0.00051	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000464	0.000509	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000464	0.000509	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000462	0.000507	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000461	0.000505	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000455	0.0005	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000454	0.000498	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000452	0.000496	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000449	0.000493	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000448	0.000492	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000445	0.000489	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SCT—polycystic ovary syndrome	0.000445	0.000488	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000439	0.000482	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000437	0.00048	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000433	0.000475	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000425	0.000467	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000424	0.000466	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000422	0.000463	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00042	0.000461	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000417	0.000458	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000417	0.000458	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000415	0.000455	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000413	0.000454	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000412	0.000452	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000412	0.000452	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000412	0.000452	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00041	0.000449	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000407	0.000447	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000405	0.000444	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000403	0.000442	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000396	0.000434	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00039	0.000428	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000389	0.000427	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000386	0.000424	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000386	0.000424	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000383	0.00042	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000382	0.000419	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000381	0.000418	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000381	0.000418	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000379	0.000416	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000374	0.000411	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000368	0.000404	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—INSR—polycystic ovary syndrome	0.000364	0.000399	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000362	0.000397	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000362	0.000397	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000359	0.000394	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000357	0.000392	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000355	0.00039	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000354	0.000388	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000353	0.000387	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000347	0.000381	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000346	0.00038	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00034	0.000374	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000337	0.00037	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000335	0.000368	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000331	0.000363	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000329	0.000361	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000325	0.000356	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000316	0.000347	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000313	0.000344	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000313	0.000344	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.00031	0.000341	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000302	0.000331	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.0003	0.00033	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000299	0.000328	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000296	0.000324	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000295	0.000324	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000293	0.000321	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000291	0.00032	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00029	0.000319	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00029	0.000318	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000287	0.000315	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000276	0.000303	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000274	0.000301	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	0.000273	0.0003	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000272	0.000299	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000272	0.000299	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000267	0.000293	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000267	0.000293	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000263	0.000289	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000262	0.000288	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00026	0.000285	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000259	0.000285	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000257	0.000282	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000255	0.00028	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000253	0.000278	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000252	0.000276	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000249	0.000273	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000247	0.000271	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00024	0.000264	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00024	0.000263	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000238	0.000261	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000237	0.000261	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000235	0.000258	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000234	0.000256	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000233	0.000256	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000229	0.000251	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000229	0.000251	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000225	0.000247	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000225	0.000247	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000225	0.000247	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000221	0.000243	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000209	0.000229	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000205	0.000225	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000199	0.000218	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000195	0.000214	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000195	0.000214	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000193	0.000211	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000192	0.00021	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	0.000188	0.000207	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000168	0.000185	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000167	0.000184	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000164	0.00018	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000164	0.00018	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	0.000162	0.000178	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	0.000161	0.000177	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000161	0.000176	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000156	0.000171	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000156	0.000171	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000148	0.000162	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000146	0.00016	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000143	0.000157	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000141	0.000154	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	0.00014	0.000153	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000138	0.000152	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	0.000137	0.000151	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000135	0.000148	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000135	0.000148	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000133	0.000146	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000133	0.000146	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000128	0.000141	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000126	0.000138	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000119	0.000131	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000103	0.000114	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000102	0.000112	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000102	0.000111	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.83e-05	9.7e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.67e-05	9.52e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	7.04e-05	7.72e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	6.11e-05	6.71e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	6e-05	6.58e-05	CbGpPWpGaD
